en.Wedoany.com Reported - Synthomer has announced the sale of its acrylate monomers business in the Czech Republic to Mutares, a Munich-based private equity firm. This decision is part of Synthomer's strategic realignment aimed at transitioning to a leaner portfolio, focusing on specialty chemicals with higher margins and greater growth potential.
The divested Acrylate Monomers business, operating under the name Synthomer a.s., is a key supplier of acrylic and related monomers in the European market. Located at the company's production site in Sokolov, Czech Republic, the business employs approximately 300 people. It not only supplies external customers but also supports Synthomer's downstream operations by supplying acrylic monomers to group companies and producing acrylic dispersions. These internal supply arrangements will remain unchanged following Mutares' takeover.
This sale represents a concrete step in Synthomer's exit from highly cyclical and capital-intensive upstream industries. As the last upstream business in the company's portfolio, Acrylate Monomers was designated as a non-core asset following a strategic review in October 2022. Synthomer CEO Michael Willome stated that this announcement is an important step in achieving the company's strategy, aimed at simplifying operations and focusing more on specialty chemical markets where the company holds a sustainable leading position. He expressed confidence in Mutares' operational capabilities to lead Acrylate Monomers into its next phase of development.
Financial data shows that in 2025, Acrylate Monomers achieved external sales of €68 million but recorded an adjusted EBITDA loss of €10 million. Affected by short-term market volatility and cost reductions, the business saw improved trading conditions in early 2026 and reached breakeven. Synthomer noted that the business requires approximately €5 million in annual capital expenditure, highlighting its capital-intensive nature. The transaction is expected to close by the end of the third quarter of 2026 and includes a cash-sharing arrangement of up to €12 million over three years. No initial payment is required at closing, and to ensure operational continuity, the divested company will receive €5 million in cash for working capital needs.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
